Waller Donald, Bolick David, Lissner Elaine, Premanandan Christopher, Gamerman Gary
Prelabs, LLC, 33 W Chicago Ave., Oak Park, IL 60302 USA.
Seraphim Life Sciences Consulting, LLC, 2158 Bonaventure Drive, Suite 101, Vienna, VA 22181 USA.
Basic Clin Androl. 2017 Apr 5;27:8. doi: 10.1186/s12610-017-0051-1. eCollection 2017.
Development of a non-hormonal long-acting reversible contraceptive for men could have a significant impact on reducing unintended pregnancies. Vasalgel™ is a high molecular weight polymer consisting of styrene-alt-maleic acid (SMA) dissolved in dimethyl sulfoxide being developed as a reversible male contraceptive device. It forms a hydrogel when implanted into the vasa deferentia, which prevents the passage of sperm. Previous studies in the rabbit have proven its efficacy, durability and rapid onset. This study evaluates the capacity to restore sperm concentrations in ejaculates after a reversal procedure.
Sodium bicarbonate was injected into the vasa deferentia after fourteen months of azoospermia following the injection of two device variations (Vasalgel 100 and Vasalgel 80). Semen samples were then collected for six months and sperm characteristics were compared to baseline levels. Samples of vasa deferentia were obtained for histological examination.
Spermatozoa were present in all subject ejaculates after the reversal procedure. Sperm concentration and sperm motility were similar to baseline levels after reversal, while sperm forward progression was significantly lower and normal acrosomes were not observed. Forward progression percentages increased linearly during six months of semen collection, however, normal acrosomes were not observed at the conclusion of the study. Histologically, several vasa deferentia were clear of the device and contained an intact epithelial lining. A smaller proportion of tissues contained residual test material. A secondary intraluminal inflammatory response was seen occasionally in the tissues containing residual material. There was no difference between the two device variations for studied parameters.
Vasalgel's prevention of sperm transport for 14 months was reversed through an intravasal injection of sodium bicarbonate. Post-reversal sperm concentrations and motility returned to baseline levels during the six-month follow up. Residual material in the vas lumen or compromised epididymal and vas deferens function may be resulting in reduced forward progression and loss of acrosomes during transit through the vas. Reduced forward progression and the lack of normal acrosomes strongly suggest impaired sperm function.
开发一种用于男性的非激素长效可逆避孕药具可能对减少意外怀孕产生重大影响。Vasalgel™是一种由溶解在二甲基亚砜中的苯乙烯-alt-马来酸(SMA)组成的高分子量聚合物,正被开发为一种可逆的男性避孕装置。当植入输精管时,它会形成一种水凝胶,阻止精子通过。先前在兔子身上进行的研究已经证明了其有效性、持久性和快速起效性。本研究评估了在进行逆转手术后恢复射精中精子浓度的能力。
在注射两种不同型号的装置(Vasalgel 100和Vasalgel 80)导致无精子症14个月后,将碳酸氢钠注入输精管。然后收集精液样本6个月,并将精子特征与基线水平进行比较。获取输精管样本进行组织学检查。
逆转手术后,所有受试者的射精中均存在精子。逆转后精子浓度和精子活力与基线水平相似,而精子前向运动明显较低,且未观察到正常顶体。在收集精液的6个月期间,前向运动百分比呈线性增加,然而,在研究结束时未观察到正常顶体。组织学上,几条输精管清除了装置且上皮内衬完整。较小比例的组织含有残留的测试材料。在含有残留材料的组织中偶尔可见继发性管腔内炎症反应。两种装置型号在研究参数方面没有差异。
通过输精管内注射碳酸氢钠可逆转Vasalgel对精子运输14个月的阻断作用。在6个月的随访期间,逆转后精子浓度和活力恢复到基线水平。管腔内的残留材料或附睾和输精管功能受损可能导致精子在通过输精管时前向运动减少和顶体丢失。前向运动减少和缺乏正常顶体强烈提示精子功能受损。